Form 8-K - Current report:
SEC Accession No. 0001019687-03-002135
Filing Date
2003-10-20
Accepted
2003-10-20 15:35:08
Documents
2
Period of Report
2003-10-15
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 titan_8k-101503.txt 8-K 3962
3 titan_8kex20-1.txt EX-20.1 10807
  Complete submission text file 0001019687-03-002135.txt   16469
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 03947797
SIC: 2836 Biological Products, (No Diagnostic Substances)